703 related articles for article (PubMed ID: 27451956)
1. The genetics and mechanisms of T cell acute lymphoblastic leukaemia.
Belver L; Ferrando A
Nat Rev Cancer; 2016 Jul; 16(8):494-507. PubMed ID: 27451956
[TBL] [Abstract][Full Text] [Related]
2. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
Gianni F; Belver L; Ferrando A
Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
[TBL] [Abstract][Full Text] [Related]
3. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
4. T-ALL: ALL a matter of Translation?
Girardi T; De Keersmaecker K
Haematologica; 2015 Mar; 100(3):293-5. PubMed ID: 25740104
[No Abstract] [Full Text] [Related]
5. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
González-García S; García-Peydró M; Alcain J; Toribio ML
Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
[TBL] [Abstract][Full Text] [Related]
6. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
7. Targeting NOTCH1 in T-ALL: Starving the dragon.
Herranz D; Ferrando AA
Cell Cycle; 2016; 15(4):483-4. PubMed ID: 26864725
[No Abstract] [Full Text] [Related]
8. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
[TBL] [Abstract][Full Text] [Related]
9. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
[TBL] [Abstract][Full Text] [Related]
10. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
Van Vlierberghe P; Pieters R; Beverloo HB; Meijerink JP
Br J Haematol; 2008 Oct; 143(2):153-68. PubMed ID: 18691165
[TBL] [Abstract][Full Text] [Related]
11. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
13. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract][Full Text] [Related]
15. Notch Partners in the Long Journey of T-ALL Pathogenesis.
Toribio ML; González-García S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674902
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
Hefazi M; Litzow MR
Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
[TBL] [Abstract][Full Text] [Related]
18.
Hof J; Kox C; Groeneveld-Krentz S; Bandapalli OR; Karawajew L; Schedel K; Kunz JB; Eckert C; Ludwig WD; Ratei R; Rhein P; Henze G; Muckenthaler MU; Kulozik AE; von Stackelberg A; Kirschner-Schwabe R
Haematologica; 2017 Jul; 102(7):e249-e252. PubMed ID: 28360149
[No Abstract] [Full Text] [Related]
19. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
[TBL] [Abstract][Full Text] [Related]
20. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
Meijerink JP
Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
